Camrese and Immune globulin intravenous and subcutaneous
Determining the interaction of Camrese and Immune globulin intravenous and subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / levonorgestrel
Brand name: Amethia, Amethia Lo, Camrese, Camrese Lo, Daysee, Introvale, Jolessa, LoSeasonique, Quartette, Quasense, Seasonale, Seasonique, Afirmelle, Altavera, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Chateal, Chateal EQ, Delyla, Enpresse-28, FaLessa, Falmina, Fayosim, Kurvelo, Larissia, Lessina, Levonest, Levora 015/30, Lillow, Lutera, Marlissa, Myzilra, Orsythia, Portia-28, Rivelsa, Setlakin, Simpesse, Sronyx, Trivora, Vienva, Alesse, Enpresse, Levlen, Levora, Lybrel, Nordette, Portia, Tri-Levlen, Triphasil-21, Triphasil-28, Trivora-28, Preven EC, Triphasil
Synonyms: Camrese (extended-cycle)
Generic Name: immune globulin intravenous and subcutaneous
Brand name: Gammagard, Gammaked, Gamunex-C, Gammagard Liquid
Synonyms: Immune globulin (intravenous and subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Camrese-Immune globulin subcutaneous
- Camrese-Immune globulin-ifas Intravenous
- Camrese-Imodium
- Camrese-Imodium A-D
- Camrese-Imodium A-D EZ Chews
- Camrese-Imodium A-D New Formula
- Immune globulin intravenous and subcutaneous-Camrese extended-cycle
- Immune globulin intravenous and subcutaneous-Camrese Lo
- Immune globulin intravenous and subcutaneous-Camrese Lo extended-cycle
- Immune globulin intravenous and subcutaneous-Canagliflozin
- Immune globulin intravenous and subcutaneous-Canagliflozin and metformin
- Immune globulin intravenous and subcutaneous-Canagliflozin and Metformin Extended-Release Tablets